Related references
Note: Only part of the references are listed.Impairment of Glioma Stem Cell Survival and Growth by a Novel Inhibitor for Survivin-Ran Protein Complex
Hacer Guvenc et al.
CLINICAL CANCER RESEARCH (2013)
Tumor-Specific Activation of the C-JUN/MELK Pathway Regulates Glioma Stem Cell Growth in a p53-Dependent Manner
Chunyu Gu et al.
STEM CELLS (2013)
Laminin alpha 2 enables glioblastoma stem cell growth
Justin D. Lathia et al.
ANNALS OF NEUROLOGY (2012)
Telomestatin Impairs Glioma Stem Cell Survival and Growth through the Disruption of Telomeric G-Quadruplex and Inhibition of the Proto-oncogene, c-Myb
Takeshi Miyazaki et al.
CLINICAL CANCER RESEARCH (2012)
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen et al.
NATURE (2012)
Radiation-Induced Reprogramming of Breast Cancer Cells
Chann Lagadec et al.
STEM CELLS (2012)
A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells
Lars Anders et al.
CANCER CELL (2011)
FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma Tumorigenesis
Nu Zhang et al.
CANCER CELL (2011)
A functional analysis of MELK in cell division reveals a transition in the mode of cytokinesis during Xenopus development
Yann Le Page et al.
JOURNAL OF CELL SCIENCE (2011)
Optimization of glioblastoma multiforme stem cell isolation, transfection, and transduction
Demirkan B. Guersel et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Chemoresistance of glioblastoma cancer stem cells - much more complex than expected
Dagmar Beier et al.
MOLECULAR CANCER (2011)
Siomycin A targets brain tumor stem cells partially through a MELK-mediated pathway
Ichiro Nakano et al.
NEURO-ONCOLOGY (2011)
CD44v6 Regulates Growth of Brain Tumor Stem Cells Partially through the AKT-Mediated Pathway
Mayumi Jijiwa et al.
PLOS ONE (2011)
Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
Kaushal Joshi et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
Potential therapeutic implications of cancer stem cells in glioblastoma
Lin Cheng et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Maternal Embryonic Leucine Zipper Kinase Is Upregulated and Required in Mammary Tumor-Initiating Cells In vivo
Lionel W. Hebbard et al.
CANCER RESEARCH (2010)
Reversing HOXA9 Oncogene Activation by PI3K Inhibition: Epigenetic Mechanism and Prognostic Significance in Human Glioblastoma
Bruno M. Costa et al.
CANCER RESEARCH (2010)
MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase-Mediated HOX/Stem Cell Gene Signature
Nathalie Gaspar et al.
CANCER RESEARCH (2010)
The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia
Satoki Nakamura et al.
CARCINOGENESIS (2010)
FoxM1 is a Novel Target of a Natural Agent in Pancreatic Cancer
Zhiwei Wang et al.
PHARMACEUTICAL RESEARCH (2010)
DNA Repair and Resistance of Gliomas to Chemotherapy and Radiotherapy
Guido Frosina
MOLECULAR CANCER RESEARCH (2009)
Thiazole Antibiotics Target FoxM1 and Induce Apoptosis in Human Cancer Cells
Uppoor G. Bhat et al.
PLOS ONE (2009)
FoxM1B Transcriptionally Regulates Vascular Endothelial Growth Factor Expression and Promotes the Angiogenesis and Growth of Glioma Cells
Yujian Zhang et al.
CANCER RESEARCH (2008)
Pten haploinsufficiency accelerates formation of high-grade astrocytomas
Chang-Hyuk Kwon et al.
CANCER RESEARCH (2008)
Maternal embryonic leucine zipper kinase is a key regulator of the proliferation of malignant brain tumors, including brain tumor stem cells
Ichiro Nakano et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression
Zheng Fu et al.
NATURE CELL BIOLOGY (2008)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target
S. Horvath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Identification of a chemical inhibitor of the oncogenic transcription factor forkhead box M1
Senthil K. Radhakrishnan et al.
CANCER RESEARCH (2006)
New treatment strategies for malignant gliomas
Sith Sathornsumetee et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
FoxM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells
MG Liu et al.
CANCER RESEARCH (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Substrate specificity and activity regulation of protein kinase MELK
M Beullens et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Forkhead box m1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase
IC Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Maternal embryonic leucine zipper kinase (MELK) regulates multipotent neural progenitor proliferation
I Nakano et al.
JOURNAL OF CELL BIOLOGY (2005)
Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe
DR Wonsey et al.
CANCER RESEARCH (2005)
Foxm1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor
VV Kalinichenko et al.
GENES & DEVELOPMENT (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Share Paper
